LAPTM4B and metastatic malignant neoplasm in the lymph nodes: Furthermore, LAPTM4B-35 expression was associated with lymphovascular invasion (P = 0.000), depth of invasion (P = 0.016) and lymph node metastasis (P = 0.029) (Table 2).